Vivos Therapeutics (NASDAQ:VVOS) Trading Up 1.4%

Vivos Therapeutics, Inc. (NASDAQ:VVOS) rose 1.4% during trading on Wednesday . The company traded as high as $2.26 and last traded at $2.18. Approximately 30,929 shares changed hands during mid-day trading, a decline of 78% from the average daily volume of 142,233 shares. The stock had previously closed at $2.15.

Vivos Therapeutics Stock Performance

The stock has a fifty day moving average of $2.30 and a 200 day moving average of $5.01. The company has a market capitalization of $7.17 million, a PE ratio of -0.22 and a beta of 7.79.

Vivos Therapeutics (NASDAQ:VVOS) last posted its quarterly earnings results on Tuesday, May 14th. The company reported ($1.63) EPS for the quarter. Vivos Therapeutics had a negative return on equity of 1,879.30% and a negative net margin of 117.06%. The business had revenue of $3.42 million during the quarter.

Institutional Trading of Vivos Therapeutics

An institutional investor recently bought a new position in Vivos Therapeutics stock. Armistice Capital LLC acquired a new position in shares of Vivos Therapeutics, Inc. (NASDAQ:VVOS) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 57,000 shares of the company’s stock, valued at approximately $709,000. Armistice Capital LLC owned approximately 4.29% of Vivos Therapeutics at the end of the most recent reporting period. Institutional investors and hedge funds own 26.35% of the company’s stock.

Vivos Therapeutics Company Profile

Vivos Therapeutics, Inc, a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.